3-chloro-N-[3-ethoxy-5-(1-fluorocyclopropyl)-1-(oxan-4-yl)pyrazol-4-yl]-1-ethylpyrazolo[3,4-d]pyrimidin-6-amine
C20H25ClFN7O2 — CID 169131509
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-chloro-N-[3-ethoxy-5-(1-fluorocyclopropyl)-1-(oxan-4-yl)pyrazol-4-yl]-1-ethylpyrazolo[3,4-d]pyrimidin-6-amine
3-chloro-N-[3-ethoxy-5-(1-fluorocyclopropyl)-1-(oxan-4-yl)pyrazol-4-yl]-1-ethylpyrazolo[3,4-d]pyrimidin-6-amine (PubChem CID 169131509) has the molecular formula C20H25ClFN7O2 and a molecular weight of 449.92 g/mol. Its IUPAC name is 3-chloro-N-[3-ethoxy-5-(1-fluorocyclopropyl)-1-(oxan-4-yl)pyrazol-4-yl]-1-ethylpyrazolo[3,4-d]pyrimidin-6-amine.
Molecular Properties
| Compound Name | 3-chloro-N-[3-ethoxy-5-(1-fluorocyclopropyl)-1-(oxan-4-yl)pyrazol-4-yl]-1-ethylpyrazolo[3,4-d]pyrimidin-6-amine |
|---|---|
| PubChem CID | 169131509 |
| Molecular Formula | C20H25ClFN7O2 |
| Molecular Weight | 449.92 g/mol |
| Exact Mass | 449.17 |
| IUPAC Name | 3-chloro-N-[3-ethoxy-5-(1-fluorocyclopropyl)-1-(oxan-4-yl)pyrazol-4-yl]-1-ethylpyrazolo[3,4-d]pyrimidin-6-amine |
| SMILES | CCOc1nn(C2CCOCC2)c(C2(F)CC2)c1Nc1ncc2c(Cl)nn(CC)c2n1 |
| InChI | InChI=1S/C20H25ClFN7O2/c1-3-28-17-13(16(21)26-28)11-23-19(25-17)24-14-15(20(22)7-8-20)29(27-18(14)31-4-2)12-5-9-30-10-6-12/h11-12H,3-10H2,1-2H3,(H,23,24,25) |
| InChIKey | ONSKNDVCMGXHNX-UHFFFAOYSA-N |
| XLogP | 4.15 |
| TPSA | 91.91 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 449.92 |
| LogP ≤ 5 | 4.15 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169131509 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.